This Opposition was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on February 14, 2022 and assigned serial number 91274501 by the TTAB.

Plaintiff:
Genmab A/S represented by MARK LERNER of DUANE MORRIS LLP.
Trademark Information: GENMAB – US Trademark Serial Number 79040923
View Trademark Status at USPTO
View Trademark Documents at USPTO

Defendant:
Biocytogen Pharmaceuticals (Beijing) Co. represented by CYNTHIA JOHNSON WALDEN of FISH & RICHARDSON P.C..
Trademark Information: RENMAB – US Trademark Serial Number 88553807
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
February 14, 2022 – FILED AND FEE
February 14, 2022 – NOTICE AND TRIAL DATES SENT; ANSWER DUE:
February 14, 2022 – INSTITUTED
March 28, 2022 – ANSWER
April 20, 2022 – P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
April 20, 2022 – SUSPENDED
July 14, 2022 – P MOT FOR EXT W/ CONSENT
July 14, 2022 – EXTENSION OF TIME GRANTED
September 21, 2022 – P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
September 21, 2022 – SUSPENDED
December 19, 2022 – P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
December 19, 2022 – SUSPENDED
March 14, 2023 – P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
March 14, 2023 – SUSPENDED
May 15, 2023 – P MOT FOR EXT W/ CONSENT
May 15, 2023 – EXTENSION OF TIME GRANTED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.